Psilocybe cubensis (Agaricales, Basidiomycota) en Ecuador
Psilocybe cubensis es una especie con propiedades alucinógenas utilizada tradicionalmente por diversas comunidades originarias, pero más recientemente, utilizada con fines recreativos, a pesar de su ilegalidad.
Giovanna Alban-J. +4 more
doaj +5 more sources
Exploring Psilocybe cubensis Strains: Cultivation Techniques, Psychoactive Compounds, Genetics and Research Gaps [PDF]
Psilocybe cubensis, a widely recognized psychoactive mushroom species, has played a significant role in both historical and modern therapeutic practices.
Eyal Kurzbaum +4 more
doaj +2 more sources
Introducción y Objetivos: Algunas especies de hongos pueden inducir alucinaciones causadas por compuestos como la psilocibina, y numerosos estudios han examinado su potencial como tratamientos para diversas enfermedades. Este trabajo tiene como objetivo
Adriana Judit Batista +5 more
doaj +2 more sources
Genetic regulation of l-tryptophan metabolism in Psilocybe mexicana supports psilocybin biosynthesis [PDF]
Background Although Basidiomycota produce pharmaceutically and ecologically relevant natural products, knowledge of how they coordinate their primary and secondary metabolism is virtually non-existent.
Paula Sophie Seibold +5 more
doaj +2 more sources
Development of a PBPK model of psilocybin/psilocin from Psilocybe cubensis (magic mushroom) in mice, rats, and humans [PDF]
Psilocybin is an active alkaloid found in magic mushrooms (Psilocybe cubensis). It is classified as a Class I Psychoactive Substance due to its psychoactive properties.
Nilubon Thaoboonruang +3 more
doaj +2 more sources
Specific and Multi-Product Clade I and Clade IV Sesquiterpene Synthases Contribute to the Psilocybe cubensis Volatilome. [PDF]
Five sesquiterpene synthases of Psilocybe cubensis were investigated in vitro and in vivo. CubF is a clade I synthase producing α‐muurolol, whereas clade IV synthases CubG1 and CubG2 produce epi‐isozizaene and β‐duprezianene. Further clade IV synthases CubH and CubI primarily make dauca‐4(11),8‐diene and β‐barbatene, respectively.
Schober S +8 more
europepmc +2 more sources
Current situation regarding psychedelics and magic mushroom in Korea [PDF]
Introduction Recently, the pros and cons have been debating in Korea even before the approval of use of medical marijuana with very strict limitations. And the next controversial topic is psychedelics.
J. S. Seo
doaj +2 more sources
Dissimilar Reactions and Enzymes for Psilocybin Biosynthesis in Inocybe and Psilocybe Mushrooms. [PDF]
Mushrooms have learned twice independently how to make the iconic magic mushroom natural product psilocybin. This article introduces the enzymes of the second pathway, found in a fiber cap mushroom. Curiously, the two pathways do not share any reaction, nor do the enzymes show a close relationship, but both pathways proceed via 4‐hydroxytryptamine as a
Schäfer T +3 more
europepmc +2 more sources
Clade III Synthases Add Cyclic and Linear Terpenoids to the Psilocybe Metabolome. [PDF]
The Psilocybe cubensis terpene synthases, CubB‐CubE, were investigated. Product formation assays identified CubB as a (3R,6E)‐(‐)‐nerolidol or linalool synthase, whereas CubC is a multiproduct synthase catalyzing the formation of β‐caryophyllene and other linear and cyclic sesquiterpenes/‐terpenoids.
Zschoche N +7 more
europepmc +2 more sources
Genetic Survey of Psilocybe Natural Products
AbstractPsilocybe magic mushrooms are best known for their main natural product, psilocybin, and its dephosphorylated congener, the psychedelic metabolite psilocin. Beyond tryptamines, the secondary metabolome of these fungi is poorly understood. The genomes of five species (P. azurescens, P. cubensis, P. cyanescens, P. mexicana, and P.
Sebastian Dörner +9 more
openaire +2 more sources

